Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Race Oncology Ltd. ( (AU:RAC) ) is now available.
Race Oncology Ltd announced the cessation of 558,040 securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This cessation may impact the company’s capital structure and could have implications for its stakeholders, reflecting on its operational and strategic positioning within the biotechnology sector.
More about Race Oncology Ltd.
Race Oncology Ltd is a company operating in the biotechnology industry, focusing on the development and commercialization of cancer therapies.
Average Trading Volume: 134,324
Technical Sentiment Signal: Sell
Current Market Cap: A$222.4M
For a thorough assessment of RAC stock, go to TipRanks’ Stock Analysis page.